glutathione s-transferases resistance New insights into S-transferases: A key to unlocking disease treatment and drug PDB-101: Molecule of the Month:
Description
Therefore, targeting or co-targeting the SLC7A11/GSH axis will have therapeutic benefit in mutant-KRAS driven tumors
Above all, results are highly individual
The enzyme of the second step, GSH2, localizes predominantly in the cytosol but also in the plastids (Wachter et al
The AAVO is rich in antibacterial components
This phenomenon is known as induced systemic resistance (ISR) (Pieterse et al., 2014)
T., Marshall, S
